PlGF concentrations were also lower among participants with a stillbirth compared to participants who delivered a liveborn infant (0.64, 95% CI: 0.41 – 1.01; p = 0.05), and participants with the composite adverse outcome variable compared to women who delivered a liveborn infant at term (0.68, 95% CI: 0.52 – 0.90; p = 0.01). This evidence concerns the gene PGF and Stillbirth.